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Eight new oleanane saponins (1-8) together with four know saponins (9-12) were isolated from the aerial parts of
Meryta denhamii. Their structures were elucidated by 1D and 2D NMR experiments including 1D TOCSY, DQF-
COSY, ROESY, HSQC, and HMBC spectroscopy, as well as ESIMS analysis. The antiproliferative activity of all
compounds was evaluated using three murine and human cancer cell lines: J774.A1, HEK-293, and WEHI-164.
In our ongoing search for new bioactive compounds from
Araliaceae plants growing at the Botanical Garden of Palermo,1,2
we have performed a phytochemical study of the aerial parts of
Meryta denhamii Seem (Araliaceae), a plant never before investi-
gated. Plants of family Araliaceae have been used as folk remedies
for the treatment of pain, rheumatic arthritis, fracture, sprains, and
lumbago in Asian countries.3 Eight new oleanane saponins (1-8)
were isolated from M. denhamii, along with four known saponins.
Since triterpenoid saponins have been reported to possess cytotoxic
activity,2,4 the antiproliferative activity of 1-8 was evaluated in
the cell lines J774.A1, HEK-293, and WEHI-164.
Results and Discussion
The n-BuOH-soluble portion of a MeOH extract of the aerial
parts of M. denhamii was subjected to Sephadex LH-20 column
chromatography, followed by RP-HPLC, to afford eight new
oleanane saponins (1-8) and four known saponins (9-12).
The negative-ion HRESIMS spectrum of 1 showed a single peak
at m/z 1021.4652 ascribable to the molecular formula C48H78O21S,
suggesting the presence of a sulfate group in the molecule. The
high-resolution daughter ion spectrum of this ion showed a largely
predominant fragment at m/z 551.3048 [M - (162 + 162 + 146)
- H]- consistent with the loss of an esterified sugar chain and
indicating that the glycosidic moiety was composed of two hexose
and one deoxyhexose unit. A minor peak at m/z 453.3372 [M -
(162 + 162 + 146) - 98 - H]-, due to elimination of H2SO4
from the negatively charged aglycone, confirmed the presence of a
sulfate group in 1.5
The 1H NMR spectrum of the aglycone moiety of compound 1
showed signals corresponding to six tertiary methyls at δ 0.73, 0.83,
0.94, 0.96, 1.00, and 1.18 and a typical H3-ax at δ 3.96 (1H, dd,
J ) 12.4, 4.5 Hz) due to the presence of a substitution at C-3. The
downfield shift observed for H-3 was indicative of substitution on
the OH group.6 Further features were a signal at δ 5.28 (1H, t, J )
3.5 Hz), ascribable to an olefinic proton, and signals at δ 3.31 (1H,
d, J ) 12.4 Hz) and 3.61 (1H, d, J ) 12.4 Hz) ascribable to protons
of a primary alcoholic function. The 13C NMR chemical shifts of
all protonated carbons, assigned unambiguously by the HSQC
spectrum, suggested a hederagenin derivative (Table 1).6 The sulfate
group was placed at C-3 on the basis of the downfield shifts of the
H-3 (δ 3.96) and C-3 (δ 82.8) signals, consistent with the presence
of a sulfate group.7,8 The sugar portion of 1 exhibited three anomeric
proton resonances (δ 5.37, d, J ) 7.5 Hz; 4.89, d, J ) 1.6 Hz;
4.47, d, J ) 7.6 Hz) and one methyl doublet (δ 1.28, d, J ) 6.2
Hz), suggesting the occurrence of one deoxyhexose unit. The
oligosaccharide structure was deduced using 1D TOCSY and 2D
NMR experiments, which indicated that two -glucopyranose and
one R-rhamnopyranose were present (Tables 2 and 3). The
configurations of the sugar units were assigned after hydrolysis of
1 with 1 N HCl. The hydrolysate was trimethylsilated, and GC
retention times of each sugar were compared with those of authentic
sugar samples prepared in the same manner. Glycosidation shifts
were observed for C-6glc-C28 (δ 68.7) and C-4glcI (δ 79.3). Chemical
shift of H-1glc (δ 5.37) and C-1glc (δ 95.5) indicated that this sugar
unit was involved in an ester linkage with the C-28 carboxylic
group.9 On the basis of these data, compound 1 was identified as
the 3-sulfate ester of 3,23-dihydroxyolean-12-en-28-oic acid 28-
O-R-L-rhamnopyranosyl-(1f4)--D-glucopyranosyl-(1f6)--D-glu-
copyranoside.
The molecular formula of 2 was established unequivocally to
be C42H68O17S on the basis of the HRESIMS negative-ion spectrum,
showing an ion peak at m/z 875.4108. The high-resolution product
ion spectrum of this species generated the same fragments detected
in the MS/MS spectrum of 1 (m/z 551.3045 and 453.3374),
suggesting that 1 and 2 had the same aglycone, but that the esterified
sugar chain of 2 consisted of only two hexose.
The NMR data (1H, 13C, 1D TOCSY, DQF-COSY, HSQC,
HMBC) of 2 in comparison to those of 1 revealed that compound
2 differed from 1 only in the absence of the terminal R-L-
rhamnopyranosyl unit. The configuration of the sugar unit was
assigned after hydrolysis of 2 with 1 N HCl. Thus, 2 was identified
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as the 3-sulfate ester of 3,23-dihydroxyolean-12-en-28-oic acid
28-O--D-glucopyranosyl-(1f6)--D-glucopyranoside.
Compound 3 was assigned a molecular formula of C65H106O31,
as determined by positive-ion HRESIMS (m/z 1405.6588 [M +
Na]+). Tandem mass spectra obtained by collision-induced dis-
sociation (CID) of ions at m/z 1405.7 showed fragments at m/z
1259.6 [M - 146 + Na]+ and 1097.5 [M - (146 + 162) + Na]+
and a predominant peak at m/z 935.5 [M - (146 + 162 + 162) +
Na]+, due to the loss of one deoxyhexose and two hexose moieties,
respectively. An intense signal at m/z 493.1 was also observed,
consistent with a sodiated three-sugar chain [(146 + 162 + 162)
+ Na]+. These results suggested that 3 had an esterified sugar chain
composed of a deoxyhexose and two hexose units. Fragment ions
detected at m/z 773.4 [M - (146 + 162 + 162) - 162 + Na]+
and 611.3 [M - (146 + 162 + 162) - (162 + 162) + Na]+
demonstrated that a second glycoside chain was also present in 3.
The 13C NMR spectrum of 3 displayed 65 carbon resonances,
of which 30 were assigned to the aglycone and 35 to the sugar
moiety. The 13C NMR spectrum (Table 2 and Experimental Section)
suggested a triterpenoid glycoside structure. The 13C NMR spectrum
of the aglycone portion exhibited resonances assigned to seven
tertiary methyl, two sp2-hybridized, one hydroxymethine (δ 91.0),
and one carboxylic (δ 178.2) carbons (Table 1). The combined
NMR data indicated that the aglycone of 3 was oleanolic acid.10
In compound 3, C-28 appeared at δ 178.2 in the 13C NMR spectrum
and H-18 appeared at δ 2.92 (dd, J ) 12.0 and 4.0 Hz) in the 1H
NMR spectrum, indicating that the carboxyl group was glycosilated.
Attachment of another glycoside chain at C-3 was suggested by
the significant downfield shift observed for this carbon in 3 relative
to the corresponding signal in oleanolic acid derivatives.10 Assign-
ments of all NMR signals of the aglycone portion were ascertained
from a combination of 1D TOCSY, DQF-COSY, and HSQC
experiments.
The sugar portion of 3 exhibited six anomeric proton resonances
(δ 5.36, d, J ) 7.5 Hz; 4.90, d, J ) 1.6 Hz; 4.68, d, J ) 7.6 Hz;
4.60, d, J ) 7.5 Hz, 4.48, d, J ) 7.6 Hz; 4.36, d, J ) 5.5 Hz) and
one methyl doublet (δ 1.30, d, J ) 6.2 Hz) in the 1H NMR spectrum
(Table 3). The 1D TOCSY and 2D NMR experiments indicated
that four -glucopyranose, one R-arabinopyranose, and one R-rham-
nopyranose groups were present (Tables 2 and 3). The configura-
tions of the sugar units were assigned after hydrolysis of 3 with 1
N HCl.
The absence of any 13C NMR glycosidation shift for the R-L-
rhamnopyranosyl and one of the -glucopyranosyl moieties indi-
cated that these sugars were terminal units. Glycosidation shifts
were observed for C-6glc-C28 (δ 69.0), C-4glcI (δ 79.3), C-3ara (δ
83.0), and C-4glcIII (δ 79.5) (Table 2). The chemical shifts of H-1glc
(δ 5.36) and C-1glc (δ 95.7) indicated that this sugar unit was
involved in an ester linkage with the C-28 carboxylic group.
Direct evidence for the sugar sequence and their linkage sites to
the aglycone was derived from the HMBC experiment, which
showed unequivocal correlations between resonances at δ 4.36 and
δ 91.0 (H-1ara-C-3), indicating that arabinose was linked to C-3
of the aglycone; a cross-peak between δ 4.60 and δ 83.0
(H-1glcIII-C-3ara) indicated that glucose III was the second unit,
Table 1. 13C NMR Data of the Aglycon Moieties of Compounds
1, 3, and 6 (CD3OD, 150 MHz)a
position
1
δC
3
δC
6
δC
1 39.5 39.9 39.8
2 25.0 26.6 26.6
3 82.8 91.0 91.0
4 43.0 39.0 39.0
5 48.5 57.0 57.2
6 18.2 19.5 18.5
7 32.5 33.7 34.2
8 41.0 40.3 40.6
9 48.2 48.8 48.2
10 37.9 37.7 37.8
11 24.0 24.6 23.8
12 124.0 124.3 123.7
13 144.3 144.2 144.0
14 43.2 42.3 42.0
15 28.0 28.2 36.6
16 24.7 23.5 74.6
17 47.6 47.0 50.0
18 42.5 42.8 41.9
19 47.0 46.7 47.7
20 31.3 30.8 30.8
21 34.0 34.5 33.0
22 33.5 34.0 36.0
23 65.2 28.0 29.3
24 64.4 16.5 17.8
25 18.5 16.0 16.6
26 18.0 18.0 16.0
27 26.0 26.2 27.7
28 178.3 178.2 177.6
29 33.5 33.4 33.0
30 24.5 23.8 24.5
a Chemical shifts are given in δ (ppm); assignments were confirmed
by HSQC and HMBC experiments.
Table 2. 13C NMR Data for Glycosyl Moieties of Compounds
1-7 (CD3OD, 600 MHz)a
position
1
δC
2
δC
3
δC
4
δC
5
δC
6
δC
7
δC
GlcC28 1 95.5 95.5 95.7 95.7 95.5 95.3 95.5
2 76.0 73.4 75.6 75.5 75.9 75.0 75.4
3 77.6 77.7 77.8 77.6 77.6 77.8 77.8
4 70.6 70.1 71.0 70.8 70.5 71.0 71.0
5 77.0 77.6 76.9 76.7 77.0 78.1 77.0
6 68.7 69.0 69.0 68.6 69.0 62.3 68.9
GlcI 1 104.1 104.3 103.9 104.0 104.0 104.2
2 74.9 72.3 75.0 74.9 75.0 75.0
3 77.7 78.3 77.0 77.8 77.5 86.3
4 79.3 71.2 79.3 79.3 78.8 70.3
5 77.8 77.9 77.2 77.0 76.9 77.6
6 62.0 62.2 62.0 62.0 62.1 62.0
Rha 1 102.8 102.5 102.6 102.3 102.4
2 72.0 72.2 72.3 72.4 72.2
3 71.7 71.9 72.0 71.9 72.0
4 73.4 73.5 73.7 73.7 73.6
5 70.2 70.3 70.5 70.5 70.0
6 18.0 18.1 18.2 18.3 18.2
GlcII 1 103.1
2 75.2
3 77.3
4 79.0
5 77.0
6 61.9
Ara 1 107.4 107.4 107.0
2 71.8 71.8 71.6
3 83.0 82.6 82.8
4 69.0 69.0 69.0
5 66.0 66.0 66.0
GlcIII 1 103.7 104.9 104.4 104.2 104.0
2 76.0 75.8 75.0 74.9 76.0
3 77.0 78.0 77.5 77.8 76.8
4 79.5 70.5 72.0 71.0 79.3
5 77.0 78.1 77.8 78.0 77.1
6 61.5 62.0 62.6 62.4 61.8
GlcIV1 104.4 104.3
2 75.0 75.5
3 77.5 78.0
4 72.0 71.1
5 77.8 77.8
6 62.6 62.6
Glucur 1 105.1 105.1
2 82.0 82.0
3 76.5 76.5
4 72.0 71.7
5 77.0 76.8
6 176.0 175.6
a Chemical shifts are given in δ (ppm); assignments were confirmed
by HSQC and HMBC experiments.
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and a cross-peak between δ 4.68 and δ 79.5 (H-1glcIV-C-4glcIII)
indicated that glucose IV was the terminal unit of the trisaccharide
chain at C-3. Similarly the sequence of the trisaccharide chain at
C-28 was indicated by the cross-peaks between C-6glc (δ 69.0) and
H-1glcI (δ 4.48) and between C-4glcI (δ 79.3) and H-1rha (δ 4.90).
Thus, compound 3 was identified as 3-O-[-D-glucopyranosyl-
(1f4)--D-glucopyranosyl-(1f3)-R-L-arabinopyranosyl] olean-12-
en-28-O-[R-L-rhamnopyranosyl-(1f4)--D-glucopyranosyl-(1f6)-
-D-glucopyranosyl] ester.
Compound 4 was obtained as an amorphous powder with the
molecular formula C59H96O26 as deduced from the HRESIMS
spectrum and confirmed by 13C NMR and 13C DEPT data. The
MS/MS spectrum of compound 4 showed a prominent fragment at
m/z 773.4 [M - (146 + 162 + 162) + Na)]+. The spectroscopic
data of the aglycone moiety of 4 were identical to those of 3. The
proton coupling network within each sugar residue was established,
using a combination of 1D TOCSY, DQF-COSY, and HSQC
experiments. Once again, direct evidence for the sugar sequence
and the linkage sites was derived from the HSQC and HMBC data.
Comparison of NMR data of the sugar moieties (Tables 2 and 3)
of 4 with those of 3 indicated that 4 differed from 3 only by the
absence of a terminal glucopyranosyl moiety on the C-3 sugar chain.
The structures of the sugar units were determined as reported for
compound 3. Thus, compound 4 was defined as 3-O-[-D-
glucopyranosyl-(1f3)-R-L-arabinopyranosyl] olean-12-en-28-O-[R-
L-rhamnopyranosyl-(1f4)--D-glucopyranosyl-(1f6)--D-glucopy-
ranosyl] ester.
Compound 5 was obtained as an amorphous powder (C60H96O28)
as deduced by HRESIMS and confirmed by 13C and 13C DEPT
NMR data. The proton coupling network within each sugar residue
was established, using a combination of 1D TOCSY, DQF-COSY,
and HSQC experiments. Direct evidence for the sugar sequence
Table 3. 1H NMR Data for Glycosyl Moieties of Compounds 1-7 (CD3OD, 600 MHz)a
position
1
δH
2
δH
3
δH
4
δH
5
δH
6
δH
7
δH
GlcC28 1 5.37 d (7.5) 5.39 5.36 d (7.5) 5.41 5.37 d (7.5) 5.36 5.37 d (7.5)
2 3.38 dd (9.5, 7.5) 3.32 3.35 dd (9.5, 7.5) 3.38 3.38 dd (9.5, 7.5) 3.32 3.40 dd (9.5, 7.5)
3 3.46 t (9.5) 3.44 3.41 t (9.5) 3.47 3.46 t (9.5) 3.64 3.45 t (9.5)
4 3.42 t (9.5) 3.47 3.46 t (9.5) 3.45 3.48 t (9.5) 3.71 3.48 t (9.5)
5 3.58 m 3.60 3.58 m 3.58 3.60 m 3.40 3.59 m
6a 3.85 dd (12.0, 5.0) 3.86 3.84 dd (12.0, 5.0) 3.83 3.85 dd (12.0, 5.0) 3.68 3.89 dd (12.0, 5.0)
6b 4.12 dd (12.0, 3.0) 4.13 4.10 dd (12.0, 3.0) 4.15 4.12 dd (12.0, 3.0) 3.84 4.10 dd (12.0, 3.0)
GlcI 1 4.47 d (7.6) 4.50 4.48 d (7.6) 4.47 4.47 d (7.6) 4.49 d (7.6)
2 3.21 dd (9.5, 7.6) 3.27 3.18 dd (9.5, 7.6) 3.21 3.21 dd (9.5, 7.6) 3.43 dd (9.5, 7.6)
3 3.53 t (9.5) 3.39 3.50 t (9.5) 3.53 3.53 t (9.5) 3.64 t (9.5)
4 3.62 t (9.5) 3.30 3.65 t (9.5) 3.62 3.64 t (9.5) 3.60 t (9.5)
5 3.30 m 3.42 3.32 m 3.38 3.32 m 3.30 m
6a 3.73 dd (12.0, 5.0) 3.68 3.70 dd (12.0, 5.0) 3.73 3.73 dd (12.0, 5.0) 3.73 dd (12.0, 5.0)
6b 3.84 dd (12.0, 3.0) 3.88 3.81 dd (12.0, 3.0) 3.84 3.84 dd (12.0, 3.0) 3.80 dd (12.0, 3.0)
Rha 1 4.89 d (1.6) 4.90 d (1.6) 4.89 4.89 d (1.6) 4.90 d (1.6)
2 3.88 dd (3.0, 1.6) 3.86 dd (3.0, 1.6) 3.89 3.90 dd (3.0, 1.6) 3.82 dd (3.0, 1.6)
3 3.70 dd (9.0, 3.0) 3.69 dd (9.0, 3.0) 3.70 3.70 dd (9.0, 3.0) 3.73 dd (9.0, 3.0)
4 3.48 t (9.0) 3.49 t (9.0) 3.48 3.48 t (9.0) 3.48 t (9.0)
5 4.03 m 4.05 m 4.03 4.03 m 4.05 m
6 1.28 d (6.2) 1.30 d (6.2) 1.28 1.28 d (6.2) 1.30 d (6.2)
GlcII 1 4.52 d (7.6)
2 3.23 dd (9.5, 7.6)
3 3.50 t (9.5)
4 3.60 t (9.5)
5 3.36 m
6 3.70 dd (12.0, 5.0)
3.81 dd (12.0, 3.0)
Ara 1 4.36 d (5.5) 4.38 4.34 d (6.0)
2 3.74 dd (5.5, 9.4) 3.77 3.71 dd (5.5, 9.4)
3 3.78 dd (1.5, 3.0) 3.80 3.77 dd (1.5, 3.0)
4 4.10 m 4.09 4.05 m
5a 3.94 dd (12.0, 3.5) 3.96 3.91 dd (12.0, 3.5)
5b 3.63 dd (12.0, 2.0) 3.65 3.62 dd (12.0, 2.0)
GlcIII 1 4.60 d (7.5) 4.60 4.62 d (7.5) 4.60 4.62 d (7.5)
2 3.32 dd (9.5, 7.5) 3.45 3.25 dd (9.5, 7.5) 3.27 3.32 dd (9.5, 7.5)
3 3.60 t (9.5) 3.50 3.38 t (9.5) 3.40 3.57 t (9.5)
4 3.64 t (9.5) 3.42 3.30 t (9.5) 3.29 3.67 t (9.5)
5 3.38 m 3.48 3.42 m 3.42 3.41 m
6 3.73 dd (12.0, 5.0) 3.70 3.70 dd (12.0, 5.0) 3.72 3.75 dd (12.0, 5.0)
3.84 dd (12.0, 3.0) 3.90 3.87 dd (12.0, 3.0) 3.88 3.88 dd (12.0, 3.0)
GlcIV1 4.68 d (7.6) 4.70 d (7.5)
2 3.30 dd (9.5, 7.6) 3.27 dd (9.5, 7.6)
3 3.34 t (9.5) 3.30 t (9.5)
4 3.32 t (9.5) 3.33 t (9.5)
5 3.40 m 3.38 m
6 3.68 dd (12.0, 5.0) 3.70 dd (12.0, 5.0)
3.83 dd (12.0, 3.0) 3.82 dd (12.0, 3.0)
Glucur 1 4.47 d (7.5) 4.47
2 3.66 dd (9.5, 7.5) 3.65
3 3.55 t (9.5) 3.55
4 3.50 t (9.5) 3.52
5 3.59 m 3.58
6
a J values are in parentheses and reported in Hz; chemical shifts are given in δ (ppm); assignments were confirmed by DQF-COSY, 1D TOCSY,
HSQC, and HMBC experiments.
1002 Journal of Natural Products, 2008, Vol. 71, No. 6 Cioffi et al.
and the linkage sites was derived from the HSQC and HMBC data.
Comparison of NMR data of the sugar moiety (Tables 2 and 3) of
5 with those of 4 indicated that 5 differed from 4 only by the
presence of one glucuronopyranosyl unit instead of one arabinopy-
ranosyl moiety on the C-3 sugar chain. The configuration of the
sugar units was determined as reported for compound 1. Thus,
compound 5 was defined as 3-O-[-D-glucopyranosyl-(1f2)--
D-glucuronopyranosyl] olean-12-en-28-O-[R-L-rhamnopyranosyl-
(1f4)--D-glucopyranosyl-(1f6)--D-glucopyranosyl] ester.
Compound 6 (molecular formula C48H76O20) showed a quasi-
molecular ion peak at m/z 971.4842 [M - H]- in the negative
HRESIMS. The 13C and 13C DEPT spectra showed 48 resonances,
of which 30 were assigned to the aglycone and 18 to the sugar
portion. The 13C NMR spectra showed, for the aglycone moiety,
signals that could be correlated unambiguously to the corresponding
proton chemical shifts from the HSQC experiment, leading to the
identification of the aglycone as echinocystic acid (Table 1).11
Analysis of the NMR data (Tables 2 and 3) of compound 6 and
comparison with those of 5 revealed 6 to differ from 5 only in the
sugar chain at C-28. The structure of the sugar chain at C-28 was
deduced using 1D TOCSY and COSY experiments, leading to the
identification of one glucopyranosyl moiety. Thus, compound 6 was
defined as 3-O-[-D-glucopyranosyl-(1f2)--D-glucuronopyra-
nosyl]echinocystic acid 28-O--D-glucopyranosyl ester.
Compound 7 had the molecular formula C71H116O37, as deter-
mined by 13C and 13C-DEPT NMR data and the [M + Na]+ peak
at m/z 1583.8 in the ESIMS spectrum. The 13C and 13C DEPT NMR
spectra showed 71 signals, of which 30 were assigned to a
triterpenoid moiety and 41 to the saccharide portion. The spectro-
scopic analysis revealed the presence of a carboxylic group located
at C-28 and was in agreement with echinocystic acid as the aglycone
of compound 7.11 Seven anomeric protons were observed in the
1H NMR spectrum of 7 at δ 4.34 (d, J ) 6.0 Hz), 4.49 (d, J ) 7.6
Hz), 4.52 (d, J ) 7.6 Hz), 4.62 (d, J ) 7.5 Hz), 4.70 (d, J ) 7.5
Hz), 4.90 (d, J ) 1.6 Hz), and 5.37 (d, J ) 7.5 Hz). The chemical
shifts of all the individual protons of the seven sugar units were
ascertained from a combination of 1D TOCSY and DQF-COSY
spectral analysis, and the 13C NMR chemical shifts (Table 2) of
their attached carbons were assigned unambiguously from the
HSQC spectrum. In this way, the sugar units were identified as
one R-arabinopyranoside, one R-rhamnopyranoside, and five -glu-
copyranoside units.12 In the HSQC experiment, glycosidation shifts
were observed for C-6glc (δ 68.9), C-3glcI (δ 86.3), C-4glcII (δ 79.0),
C-3ara (δ 82.8), and C-4glcIII (δ 79.3). The absence of any
glycosidation shifts for one glycopyranosyl unit and one rham-
nopyranoside suggested that these sugars were terminal units. The
anomeric carbon signal at δ 95.5 (C-1glc) and the carbonyl signal
at δ 177.6 revealed the presence of an ester glycosidic linkage
between C-28 and one glucopyranosyl unit.9 Direct evidence for
the sugar chain linked at C-3 was derived from the results of the
HMBC experiment, which showed unequivocal correlation peaks
between H-1ara-C-3, H-1glcIII-C-3ara, and H-1glcIV-C-4glcIII. Simi-
larly, the sequence of the tetrasaccharide chain at C-28 was indicated
by the cross-peaks between H-1rha-C-4glcII, H-1glcII-C-3glcI, and
H-1glcI-C-6glc. The configuration of the sugar units was determined
as reported for compound 1. Thus, compound 7 was established as
3-O-[-D-glucopyranosyl-(1f4)--D-glucopyranosyl-(1f3)-R-L-
arabinopyranosyl]echinocystic acid 28-O-[R-L-rhamnopyranosyl-
(1f4)--D-glucopyranosyl-(1f3)--D-glucopyranosyl-(1f6)--D-
glucopyranosyl] ester.
Compound 8 (C71H116O36) was identified as a further triterpene
derivative possessing saccharide chains at C-3 and C-28. Com-
parison of NMR spectroscopic data of compound 8 (Experimental
Section) with those of compound 7 showed these to be identical in
the sugar portion but different in the aglycone. The spectroscopic
data for the aglycone moiety of 8 were identical to those of
compound 3. Therefore, the structure 3-O-[-D-glucopyranosyl-
(1f4)--D-glucopyranosyl-(1f3)-R-L-arabinopyranosyl] olean-12-
en-28-O-[R-L-rhamnopyranosyl-(1f4)--D-glucopyranosyl-(1f3)-
-D-glucopyranosyl-(1f6)--D-glucopyranosyl] ester was assigned
to 8.
The four known triterpene glycosides were identified as the
3-sulfate ester of 3-hydroxyolean-12-en-28-oic acid 28-O-R-L-
rhamnopyranosyl-(1f4)--D-glucopyranosyl-(1f6)--D-glucopy-
ranoside (9),13 3-sulfate ester of 3-hydroxyolean-12-en-28-oic acid
28-O-[-D-glucopyranosyl-(1f6)]--D-glucopyranoside (10),14 3-
O-R-L-arabinopyranosylolean-12-en-28-O-R-L-rhamnopyranosyl-
(1f4)--D-glucopyranosyl-(1f6)--D-glucopyranoside (11),15 and
3-O-R-L-arabinopyranosyl-(1f2)--D-glucopyranosylolean-12-en-
28-O--D-glucopyranoside (12),16 by detailed NMR and MS
analyses and comparison with literature data.
The antiproliferative activity of compounds 1-12 was evaluated
against the J774.A1, WEHI-164, and HEK-293 cell lines (Table
4). Sulfate derivatives 1, 2, 9, and 10 were completely inactive.
Compounds 6 and 7, having echinocystic acid as the aglycone, were
the most active constituents, while compounds 3-5, 8, 11, and 12,
having oleanolic acid as the aglycone, were low in activity. Absence
of an R-OH function at C-16 of the oleanane skeleton reduced the
antiproliferative activity, as was observed for similar derivatives
tested previously.12
Experimental Section
General Experimental Procedures. Optical rotations were measured
on a Perkin-Elmer 241 polarimeter equipped with a sodium lamp (589
nm) and a 1 dm microcell. NMR experiments were performed on a
Bruker DRX-600 spectrometer at 300 K. 2D NMR spectra were
acquired in CD3OD in the phase-sensitive mode with the transmitter
set at the solvent resonance and TPPI (time proportional phase
increment) used to achieve frequency discrimination in the ω1 dimen-
sion. The standard pulse sequence and phase cycling were used for
DQF-COSY, TOCSY, HSQC, HMBC, and ROESY experiments. The
NMR data were processed on a Silicon Graphics Indigo2 Workstation
using UXNMR software. ESIMS and MS/MS spectra (positive and
negative mode) were obtained from an LCQ Advantage ThermoFinni-
gan spectrometer, equipped with Xcalibur software. HRESIMS and
HRESIMS/MS spectra were acquired in positive- and negative-ion
mode using a Q-TOF Premier spectrometer equipped with a nanospray
source. Column chromatography was performed on Sephadex LH-20.
HPLC separations were conducted using a Shimadzu LC-8A series
pumping system equipped with a Waters R401 refractive index detector
and Shimadzu injector on a C18 µ-Bondapak column (30 cm × 7.8
mm, flow rate 2.0 mL min-1). GC analyses were performed using a
Dani GC 1000 instrument on a L-CP-Chirasil-Val column (0.32 mm
× 25 m).
Plant Material. The aerial parts of M. denhamii were collected in
Palermo, Italy, during April 2002 and were identified by Prof. Giuseppe
Table 4. In Vitro Antiproliferative Activity of Compounds 1-12a
cell line (IC50 µM)
compound J774.A1b HEK-293c WEHI-164d
1 nde nde nde
2 nde nde nde
3 3.0 ( 0.001 nde nde
4 3.6 ( 0.007 nd 7 ( 0.03
5 6.9 ( 0.012 nde nde
6 0.19 ( 0.001 0.23 ( 0.012 0.34 ( 0.036
7 0.32 ( 0.007 1.3 ( 0.021 1.7 ( 0.023
8 9.0 ( 0.032 nde nde
9 nde nde nde
10 nde nde nde
11 2.5 ( 0.022 nde 3.4 ( 0.03
12 3.9 ( 0.022 nde 4.6 ( 0.03
6-MPf 0.003 ( 0.005 0.007 ( 0.004 0.015 ( 0.006
a The IC50 value is the concentration of compound that affords a 50%
reduction in cell growth (after a 3-day incubation). b J774.A1 ) murine
monocyte/macrophage cell lines. c HEK-293 ) human epithelial kidney
cell lines. d WEHI-164 ) murine fibrosarcoma cell lines. e nd ) not
detectable. f 6-MP ) 6-mercaptopurine.
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Venturella of the Dipartimento di Scienze Botaniche, University of
Palermo, Italy, where a voucher specimen (PAL 70577) is deposited.
Extraction and Isolation. The dried, powdered M. denhamii plant
material (400 g) was defatted with n-hexane and then extracted with
MeOH (3 × 2 L) to give 22.5 g of extract. The MeOH extract was
dissolved in H2O, and this was partitioned between n-BuOH and AcOEt,
to afford an n-BuOH-soluble portion (9 g) and AcOEt portion (5 g). A
portion of the n-BuOH residue (4.0 g) was separated on a Sephadex
LH-20 column, using MeOH as eluent. Fractions were collected,
analyzed by TLC (silica 60 F254 gel-coated glass sheets with
n-BuOH-HOAc-H2O (60:15:25) and CHCl3-MeOH-H2O (40:9:1)),
and grouped to obtain eight fractions (1-8).
Fraction 2 (120 mg) was purified by preliminary SPE followed by
RP-HPLC with MeOH-H2O (3:2) to afford compounds 7 (8.0 mg)
and 8 (14.0 mg). Fraction 3 (173 mg) was chromatographed using RP-
HPLC (MeOH-H2O (3:2)) to yield compounds 3 (6.5 mg), 4 (22 mg),
and 11 (10 mg). Fractions 4 (80 mg) and 5 (30 mg) were subjected to
RP-HPLC with MeOH-H2O (1:1) to yield compounds 5 (4.5 mg) and
6 (12 mg) from fraction 4, and 12 (22 mg) from fraction 5, respectively.
Fraction 6 (250 mg) was purified by preliminary SPE followed by RP-
HPLC with MeOH-H2O (1:1) to afford compounds 1 (30.0 mg), 2
(9.0 mg), 9 (8.0 mg), and 10 (8.0 mg).
Compound 1: amorphous powder; [R]D25 +1.12 (c 0.1, MeOH);
1H NMR data of the aglycone (CD3OD, 600 MHz) δ 0.73 (3H, s, Me-
23), 0.83 (3H, s, Me-25), 0.94 (3H, s, Me-29), 0.96 (3H, s, Me-30),
1.00 (3H, s, Me-26), 1.18 (3H, s, Me-27), 3.96 (1H, dd, J ) 12.4, 4.5
Hz, H-3); 3.31 (1H, d, J ) 12.4 Hz, H-23a), 3.61(1H, d, J ) 12.4 Hz,
H-23b), 5.28 (1H, t, J ) 3.5 Hz, H-12); 13C NMR data of the aglycone,
see Table 1; 1H and 13C NMR of the sugar moiety, see Tables 2 and 3;
HRESIMS m/z 1021.4652 [M - H]- (calcd for C48H77O21S: 1021.4669);
HRESIMS/MS (parent ion 1021.4652) m/z 551.3048 [M - (146 +
162 + 162) - H]- (calcd for C30H47O7S, 551.3043), 453.3372 [M -
(146 + 162 + 162) - 98 - H]- (calcd for C30H45O3, 453.3369).
Compound 2: amorphous powder; [R]D25 +15.2 (c 0.1, MeOH);
1H and 13C NMR data of the aglycone were superimposable on those
of 1; 1H and 13C NMR of the sugar moiety, see Tables 2 and 3;
HRESIMS m/z 875.4108 [M - H]- (calcd for C42H67O17S, 875.4090);
HRESIMS/MS (parent ion 875.4108) m/z 551.3045 [M - (162 + 162)
- H]- (calcd for C30H47O7S, 551.3043), 453.3374 [M - (162 + 162)
- 98 - H]- (calcd for C30H45O3, 453.3369).
Compound 3: amorphous powder; [R]D25 +39.9 (c 0.1, MeOH);
1H NMR data of the aglycone (see ref 17); 13C NMR data of the
aglycone, see Table 1; 1H and 13C NMR of the sugar moieties, see
Tables 2 and 3; HRESIMS m/z 1405.6588 [M + Na]+ (calcd for
C65H106O31Na, 1405.6616); MS/MS (parent ion 1405.7) m/z 1259.6 [M
- 146 + Na]+, 1097.5 [M - (146 + 162) + Na]+, 935.5 [M - (146
+ 162 + 162) + Na]+, 773.4 [M - (146 + 162 + 162) - 162 +
Na]+, 611.3 [M - (1462 + 162 + 162) - (162 + 162) + Na]+, 493.1
[(146 + 162 + 162) + Na]+.
Compound 4: amorphous powder; [R]D25 42.5 (c 0.1, MeOH); 1H
and 13C NMR of the aglycone were superimposable on those of 3; 1H
and 13C NMR of the sugar moieties, see Tables 2 and 3; HRESIMS
m/z 1243.6039 [M + Na]+ (calcd for C59H96O26Na, 1243.6088); MS/
MS (parent ion 1243.6) m/z 1097.4 [M - 146 + Na)]+, 935.4 [M -
(146 + 162) + Na)]+, 773.4 [M - (146 + 162 + 162) + Na)]+.
Compound 5: amorphous powder; [R]D25 23.6 (c 0.1, MeOH); 1H
and 13C NMR of the aglycone were superimposable on those of 3; 1H
and 13C NMR of the sugar moieties, see Tables 2 and 3; HRESIMS
m/z 1263.6018 [M - H]- (calcd for C60H95O28, 1263.6008); MS/MS
(parent ion 1263.6) m/z 793.5 [M - (146 + 162 + 162) - H]-.
Compound 6: amorphous powder; [R]D25 40.3 (c 0.1, MeOH); 1H
NMR data of the aglycone, see ref 6; 13C NMR data of the aglycone,
see Table 1; 1H and 13C NMR of the sugar moieties, see Tables 2 and
3; HRESIMS m/z 971.4842 [M - H]- (calcd for C48H75O20, 971.4852);
MS/MS (parent ion 971.5) m/z 809.4 [M - 162 - H]-.
Compound 7: amorphous powder; [R]D25 +36.0 (c 0.1, MeOH);
1H and 13C NMR of the aglycone, see ref 6; 1H and 13C NMR of the
sugar moieties, see Tables 2 and 3; ESIMS m/z 1583.8 [M + Na]+
(calcd for C71H116O37Na, 1583.7182).
Compound 8: amorphous powder; [R]D25 45.1 (c 0.1, MeOH); 1H
and 13C NMR of the aglycone were superimposable with those of
compound 3; 1H and 13C NMR of the sugar moieties were superim-
posable with those of compound 7; ESIMS m/z 1567.8 [M + Na]+
(calcd for C71H116O36Na, 1567.7182).
Acid Hydrolysis of Compounds 1-8. A solution of each compound
(2.0 mg) in 1 N HCl (1 mL) was stirred at 80 °C in a stoppered vial
for 4 h. After cooling, the solution was evaporated under a stream of
N2. Each residue was dissolved in 1-(trimethylsilyl)imidazole and
pyridine (0.2 mL), and the solution was stirred at 60 °C for 5 min.
After drying the solution, the residue was partitioned between H2O
and CHCl3. The CHCl3 layer was analyzed by GC using a L-CP-
Chirasil-Val column (0.32 mm × 25 m). Temperatures of the injector
and detector were 200 °C for both. A temperature gradient system was
used for the oven, starting at 100 °C for 1 min and increasing up to
180 °C at a rate of 5 °C/min. Peaks of the hydrolysate were detected
by comparison with retention times of authentic samples of D-glucuronic
acid, D-glucose, L-arabinose, and L-rhamnose (Sigma Aldrich) after
treatment with 1-(trimethylsilyl)imidazole in pyridine.
Antiproliferative Assay. The J774.A1 murine monocyte/macroph-
age, WEHI-164 murine fibrosarcoma, and HEK-293 human epithelial
kidney cells were grown as reported previously.18 All reagents for cell
culture were from Hy-Clone (Euroclone, Paignton Devon, U.K.); MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-phenyl-2H-tetrazolium bromide] and
6-mercaptopurine (6-MP) were from Sigma Chemicals (Milan, Italy).
The J774.Al, WEHI-164, and HEK-293 (3.4 × 104 cells) were plated
on 96-well microtiter plates and allowed to adhere at 37 °C in 5%
CO2 and 95% air for 2 h. The medium was then replaced with 50 µL
of fresh medium, a 75 µL aliquot of 1:4 serial dilution of each test
compound was added, and then the cells were incubated for 72 h. In
some experiments, serial dilutions of 6-MP were added. The cell
viability was assessed through an MTT conversion assay.18–20 The
optical density (OD) of each well was measured with a microplate
spectrophotometer (Titertek Multiskan MCC/340) equipped with a 620
nm filter. The viability of each cell line in response to treatment with
tested compounds and 6-MP was calculated as % dead cells ) 100 -
(OD treated/OD control) × 100. Table 4 shows the results expressed
as IC50 values (µM), the concentration that inhibited cell growth by
50% as compared to the control.
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